Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the PK Lead-in Phase of this study is: *To evaluate the steady state pharmacokinetics (PK) and confirm the dose of sofosbuvir (SOF) in HCV-infected pediatric subjects The primary objectives of the Treatment Phase of this study are: *To evaluate the safety and tolerability of SOF + RBV for 12 or 24 weeks in HCV-infected pediatric subjects with genotype (GT) GT-2 or GT-3, respectively
Inclusion criteria
- Chronic hepatitis C virus infection